Considering the background of HCC, the impact of panitumumab on its receptor of target and downstream major signaling activators, AKT and ERK, involved in thyroid tumorigenesis, was analyzed in an HCC cell line model with a NHG. The gene discussed is AKT1; the disease is thyroiditis.